Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Metab Cardiovasc Dis ; 31(5): 1622-1634, 2021 05 06.
Article in English | MEDLINE | ID: mdl-33810953

ABSTRACT

BACKGROUND AND AIMS: It has been demonstrated that maternal low protein during development induces mitochondrial dysfunction and oxidative stress in the heart. Moderate-intensity exercise in early life, conversely, increases the overall cardiac health. Thus, we hypothesize that moderate-intensity exercise performed during young age could ameliorate the deleterious effect of maternal protein deprivation on cardiac bioenergetics. METHODS AND RESULTS: We used a rat model of maternal protein restriction during gestational and lactation period followed by an offspring treadmill moderate physical training. Pregnant rats were divided into two groups: normal nutrition receiving 17% of casein in the diet and undernutrition receiving a low-protein diet (8% casein). At 30 days of age, the male offspring were further subdivided into sedentary (NS and LS) or exercised (NT and LT) groups. Treadmill exercise was performed as follows: 4 weeks, 5 days/week, 60 min/day at 50% of maximal running capacity. Our results showed that a low-protein diet decreases oxidative metabolism and mitochondrial function associated with higher oxidative stress. In contrast, exercise rescues mitochondrial capacity and promotes a cellular resilience to oxidative stress. Up-regulation of cardiac sirtuin 1 and 3 decreased acetylation levels, redeeming from the deleterious effect of protein restriction. CONCLUSION: Our findings show that moderate daily exercise during a young age acts as a therapeutical intervention opposing the harmful effects of a maternal diet restricted in protein.


Subject(s)
Diet, Protein-Restricted , Heart Diseases/prevention & control , Malnutrition/therapy , Mitochondria, Heart/enzymology , Oxidative Stress , Physical Conditioning, Animal , Prenatal Exposure Delayed Effects , Sirtuins/metabolism , Age Factors , Animals , Antioxidants/metabolism , Energy Metabolism , Female , Heart Diseases/enzymology , Heart Diseases/physiopathology , Male , Malnutrition/enzymology , Malnutrition/physiopathology , Maternal Nutritional Physiological Phenomena , Nutritional Status , Pregnancy , Rats, Wistar , Reactive Oxygen Species/metabolism , Running , Time Factors
2.
J Cell Biochem ; 120(5): 7341-7352, 2019 May.
Article in English | MEDLINE | ID: mdl-30368910

ABSTRACT

Overweight and obesity are established factors underpin several metabolic impairments, including the cardiovascular. Although the diversity of factors involved in overweight/obesity-induced cardiovascular diseases, mitochondria has been highlighted due to its role in cardiac metabolism. As obesity can be originated in early postnatal life, the current study evaluates the effects of neonatal overfeeding on the cardiac mitochondrial bioenergetics and oxidative balance in rats that underwent an ischemia-reperfusion insult. Seventy-two hours after delivery, Wistar rat litters were randomly assigned into the control (C; nine pups per mother) and the Overfed (OF; three pups per mother) groups throughout the lactation period. At weaning, male offspring were fed with laboratory chow ad libitum until sacrifice at 30 and 60 days of life. Mitochondrial heart bioenergetics and oxidative balance showed to be deeply affected by neonatal overfeeding at both ages. Interestingly, after ischemia-reperfusion insult I/R (Langendorff or mineral oil incubation), most parameters evaluated in OF animals were not influenced by additional ischemic-reperfusion injury. Our findings demonstrated that suckling overfeeding deregulates cardiac mitochondrial alike to ischemia-reperfusion insult by disengaging electrical mitochondrial coupling and potentiate oxidative stress, wherein the neonatal overfeeding shows to be so detrimental as I/R. Our findings support the concept that nutritional insults in the critical development periods increase the risk for cardiovascular disease and mitochondria impairments throughout life while oxidative damage change between molecular targets.

3.
Life Sci ; 145: 42-50, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26687449

ABSTRACT

AIMS: The present study investigates the effects of neonatal serotonin modulation in female rats on cardiac parameters related to hemodynamics and oxidative metabolism in the mature animal. MAIN METHODS: Female Wistar rat pups were administered daily subcutaneous injections of fluoxetine (Fx-treated group) or vehicle solution (Ct-group) from the 1st to 21st day of life. At 60days of age, animals from both groups were either used for cardiovascular evaluation or sacrificed for tissue collection for biochemical assays. KEY FINDINGS: We found that body weight in the Fx-treated group was less than that in the control. When analyzing hemodynamic parameters (i.e., arterial blood pressure, heart rate-HR, sympathetic and vagal tonus, or intrinsic HR), we did not observe significant difference in the Fx-treated group. Evaluating oxidative stress in brainstem and heart by measuring carbonyl content and malondialdehyde-MDA formation, we observe a decrease in carbonyl content only in the Fx-treated group (60.3%, in brainstem; 58.2%, in heart), without difference in the MDA levels. This observation is consonant with an increase in superoxide dismutase-SOD and catalase-CAT activity in brainstem and heart in the Fx-treated group (SOD: 82.7% and CAT: 23.7 in brainstem; SOD: 60.6%, and CAT: 40.7 in heart), with no changes in glutathione S-transferase activity and reduced glutathione levels. With regard to oxidative metabolism markers, citrate synthase activity was higher in brainstem in the Fx-treated group (20%). SIGNIFICANCE: Our data suggest that serotonin modulation by Fx-treatment at an early age does not induce hemodynamic alteration, although it modulates oxidative metabolism in cardiac-related tissues.


Subject(s)
Fluoxetine/pharmacology , Heart/physiology , Hemodynamics , Oxidative Stress , Selective Serotonin Reuptake Inhibitors/pharmacology , Serotonin/metabolism , Animals , Animals, Newborn , Catalase/metabolism , Female , Fluoxetine/administration & dosage , Glutathione/metabolism , Glutathione Transferase/metabolism , Heart/drug effects , Hemodynamics/drug effects , Malondialdehyde/metabolism , Oxidative Stress/drug effects , Rats, Wistar , Selective Serotonin Reuptake Inhibitors/administration & dosage , Superoxide Dismutase/metabolism
4.
Can J Physiol Pharmacol ; 92(4): 330-7, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24708216

ABSTRACT

The brain, more than any other organ in the body, is vulnerable to oxidative stress damage, owing to its requirement for high levels of oxygenation. This is needed to fulfill its metabolic needs in the face of relatively low levels of protective antioxidants. Recent studies have suggested that oxidative stress is directly involved in the etiology of both eating and anxiety behavior. The aim of this study was to evaluate the effect of fluoxetine-inhibited serotonin reuptake in nursing rat neonates on behavior and on oxidative stress in the hypothalamus and the hippocampus; brain areas responsible for behavior related to food and anxiety, respectively. The results show that increased serotonin levels during a critical period of development do not induce significant differences in food-related behavior (intake and satiety), but do result in a in a significant decrease in anxiety. Measurements of oxidative stress showed a significant reduction of lipid peroxidation in the hippocampus (57%). In the hypothalamus, antioxidant enzymes were unchanged, but in the hippocampus, the activity of catalase and glutathione-S-transferase was increased (80% and 85% respectively). This suggests that protecting neural cells from oxidative stress during brain development contributes to the anxiolytic effects of serotonin.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety/prevention & control , Behavior, Animal/drug effects , Fluoxetine/therapeutic use , Hippocampus/drug effects , Oxidative Stress/drug effects , Selective Serotonin Reuptake Inhibitors/therapeutic use , Animals , Animals, Newborn , Anti-Anxiety Agents/pharmacology , Anxiety/metabolism , Anxiety/psychology , Behavior, Animal/physiology , Body Weight/drug effects , Eating/drug effects , Fluoxetine/pharmacology , Hippocampus/metabolism , Hypothalamus/drug effects , Hypothalamus/metabolism , Lipid Metabolism/drug effects , Rats , Rats, Wistar , Serotonin/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...